UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evidence for a two-stage disability progression in multiple sclerosis

Brain (London, England : 1878), 2010-07, Vol.133 (7), p.1900-1913

2010

Volltextzugriff (PDF)

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS

Neurology, 2011-10, Vol.77 (16), p.1551-1560

2011

Volltextzugriff (PDF)

Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial

Neurology, 2012-04, Vol.78 (17), p.1315-1322

2012

Volltextzugriff (PDF)

Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada

Journal of neurology, neurosurgery and psychiatry, 2012-01, Vol.83 (1), p.61-66

2012

Volltextzugriff (PDF)

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2007-03, Vol.68 (13), p.977-984

2007

Volltextzugriff (PDF)

Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years

Multiple sclerosis, 2016-01, Vol.22 (1), p.112-116

2016

Volltextzugriff (PDF)

Beta-interferon exposure and onset of secondary progressive multiple sclerosis

European journal of neurology, 2015-06, Vol.22 (6), p.990-1000

2015

Volltextzugriff (PDF)

‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study

Multiple sclerosis, 2013-04, Vol.19 (4), p.458-465

2013

Volltextzugriff (PDF)

Down to size: Exploring the influence of plastic particle Dimensions on physiological and nervous responses in early-stage zebrafish

Environmental pollution (1987), 2024-06, Vol.351, p.124094, Article 124094

2024

Volltextzugriff (PDF)

Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know

Multiple sclerosis, 2013-03, Vol.19 (3), p.259-265

2013

Volltextzugriff (PDF)

Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: Preparation and physicochemical characterization

International journal of pharmaceutics, 2006-05, Vol.314 (2), p.127-136

2006

Volltextzugriff (PDF)

Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis

Multiple sclerosis, 2010-06, Vol.16 (6), p.670-677

2010

Volltextzugriff (PDF)

High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study

Multiple sclerosis, 2011-03, Vol.17 (3), p.361-367

2011

Volltextzugriff (PDF)

Randomized Trial of Thymectomy in Myasthenia Gravis

The New England journal of medicine, 2016-08, Vol.375 (6), p.511-522

2016

Volltextzugriff (PDF)

Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study

European journal of neurology, 2014-06, Vol.21 (6), p.835-844

2014

Volltextzugriff (PDF)

Fulminant liver failure during interferon beta treatment of multiple sclerosis

Neurology, 2001-05, Vol.56 (10), p.1416-1416

2001

Volltextzugriff (PDF)

Reappraisal of Lhermitte’s sign in multiple sclerosis

Multiple sclerosis, 2005-08, Vol.11 (4), p.398-402

2005

Volltextzugriff (PDF)

Longitudinal changes in myelin water fraction in two MS patients with active disease

Journal of the neurological sciences, 2009-01, Vol.276 (1), p.49-53

2009

Volltextzugriff (PDF)

A full genome search in multiple sclerosis

Nature genetics, 1996-08, Vol.13 (4), p.472-476

1996

Volltextzugriff (PDF)

A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain

Neurology, 2000-11, Vol.55 (10), p.1506-1510

2000

Volltextzugriff (PDF)

Neutralizing antibodies and interferon treatment of multiple sclerosis: addressing the open questions

Multiple sclerosis, 2007-05, Vol.13 (1_suppl), p.5-7

Oger, J.

2007

Volltextzugriff (PDF)

Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease

Acta neurologica Scandinavica, 2006-08, Vol.114 (2), p.124-132

2006

Volltextzugriff (PDF)

Binding antibodies: Vancouver's perspective

Multiple sclerosis, 2007-05, Vol.13 (1_suppl), p.36-43

2007

Volltextzugriff (PDF)

Reduced effectiveness of long-term interferon-β treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study

Multiple sclerosis, 2007-11, Vol.13 (9), p.1127-1137

2007

Volltextzugriff (PDF)

Depression and multiple sclerosis

Neurology, 1996-03, Vol.46 (3), p.628-632

1996

Volltextzugriff (PDF)

1 – 25 von 999

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(747)
Mit Volltextzugriff
(725)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(459)
MEDLINE
(386)
Elsevier ScienceDirect Journals Collection
(329)
EZB Electronic Journals Library
(291)
Journals@Ovid
(198)
IngentaConnect Journals
(170)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(148)
Publisher website
(143)
Wiley-Blackwell Journals
(78)
Wiley Online Library
(62)
SAGE Publications
(36)
Oxford journals
(33)
Taylor & Francis Journals Complete
(23)
Springer Journals
(23)
Taylor & Francis
(21)
Oxford Journals 2020 Medicine
(19)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(18)
JSTOR
(18)
Ebook Central Perpetual and DDA
(17)
eBooks on EBSCOhost
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Evidence for a two-stage disability progression in multiple sclerosis

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS

Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial

Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years

Beta-interferon exposure and onset of secondary progressive multiple sclerosis

‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study

Down to size: Exploring the influence of plastic particle Dimensions on physiological and nervous responses in early-stage zebrafish

Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know

Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: Preparation and physicochemical characterization

Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis

High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study

Randomized Trial of Thymectomy in Myasthenia Gravis

Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study

Fulminant liver failure during interferon beta treatment of multiple sclerosis

Reappraisal of Lhermitte’s sign in multiple sclerosis

Longitudinal changes in myelin water fraction in two MS patients with active disease

A full genome search in multiple sclerosis

A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain

Neutralizing antibodies and interferon treatment of multiple sclerosis: addressing the open questions

Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease

Binding antibodies: Vancouver's perspective

Reduced effectiveness of long-term interferon-β treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study

Depression and multiple sclerosis

Suchergebnisse filtern